Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
1,092.741,095.951,103.321,094.72
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
613.36613.36613.36609.50
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
1,176.791,176.521,182.251,166.69
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
1,755.541,759.231,766.301,746.04
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
635.15635.20636.89630.09
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
848.01852.52855.78849.58
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
217.86217.86219.52217.86
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
3,417.353,452.773,536.033,450.39
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
913.36915.10920.43904.57
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
1,462.381,461.131,464.531,446.02
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
2,423.142,428.712,448.692,424.63
ZEAL:CPH
Zealand Pharma A/S
DKK 341.20
-1.10%
(-3.80) 1D
May 8, 5:00:00 PM GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for ZEAL...
Open
DKK 345.50
High
DKK 345.50
Low
DKK 325.40
Mkt. cap
24.40B
Avg. vol.
367.58K
Volume
484.34K
52-wk high
DKK 556.00
52-wk low
DKK 233.50
Shares outstanding
71.53M
No. of employees
491
News stories
From sources across the web
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees491
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
9.09B
49.57M
68.92M
34.00M
Cost of goods sold
410.00K
-
-
-
Cost of revenue
410.00K
-
-
-
Research and development expenses
464.14M
320.04M
530.07M
469.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110.46M
190.85M
91.81M
104.00M
Operating expense
749.45M
510.89M
621.88M
573.00M
Total operating expenses
749.86M
510.89M
621.88M
573.00M
Operating income
8.34B
-461.32M
-552.97M
-539.00M
Other non operating income
2.98M
-17.59M
-7.23M
172.00M
EBT including unusual items
8.11B
-366.73M
-406.51M
-394.00M
EBT excluding unusual items
8.11B
-383.62M
-460.20M
-394.00M
Income tax expense
537.32M
37.50M
-27.39M
-
Effective tax rate
6.62%
-10.23%
6.74%
-
Other operating expenses
174.85M
-
1.00K
-
Net income
7.57B
-404.23M
-379.12M
-394.00M
Net profit margin
83.33%
-815.50%
-550.12%
-1,158.82%
Earnings per share
105.61
-5.75
-5.19
-5.58
Interest and investment income
56.36M
108.95M
102.41M
-
Interest expense
-7.34M
-7.00M
-7.07M
-27.00M
Net interest expenses
49.02M
101.95M
95.34M
-27.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.34B
-454.10M
-550.48M
-529.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more